✦ LIBER ✦

Acute myelocytic leukemia following prolonged streptozotocin therapy

✍ Scribed by Mark R. Green; Richard E. Anderson

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 261 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810415)47:8<1963::aid-cncr2820470809>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute non-lymphocytic leukemia following

Acute non-lymphocytic leukemia following multimodality therapy for retinoblastoma

✍ Les White; Jorge A. Ortega; Kuang L. Ying 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 1 views

Cardiac arrest due to hyperkalemia follo

Cardiac arrest due to hyperkalemia following therapy for acute lymphoblastic leukemia

✍ Deborah Wilson; Alan Stewart; James Szwed; Lawrence H. Einhorn 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

Comparative study of cytosine arabinosid

Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

✍ Dr. Robert W. Carey; Manuel Ribas-Mundo; Rose Ruth Ellison; Oliver Glidewell; St 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 2 views

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY OF HODGKIN'S DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE)

✍ J. H. LIPTON; M. GOSPODAROWICZ; S. REINGOLD 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

A 26-year-old man developed myelodysplasia rapidly progressing to acute myelomonocytic leukemia 3 years after receiving three cycles of ABVD chemotherapy and upper mantle and upper abdomen radiotherapy for stage IA Hodgkin's disease. This represents the fourth such case reported. The risk of seconda

Low dose interleukin-2 following intensi

Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission

✍ Richard M. Stone; Daniel J. DeAngelo; Anna Janosova; Ilene Galinsky; Christine C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 2 views

## Abstract The most important problem in the therapy of patients with acute myeloid leukemia (AML) is relapse after intensive therapy. We sought to determine if interleukin‐2 (low‐dose with intermittent boluses) administration could be feasibly administered after standard therapy to potentiate ant

Long-term follow-up of three randomized

Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia

✍ Ellin Berman; Peter Wiernik; Ralph Vogler; Enrique Vélez-Gárcia; Alfred Bartoluc 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

BACKGROUND. Most clinical trials for acute leukemia have reported results after